2020 ASCO Virtual Direct™ Highlights
N

2020 ASCO Update on Lymphomas: Brentuximab Vedotin vs. Pembrolizumab - Which Single Agent Should You Pick First for R/R cHL?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Neha Mehta-Shah
By 2020 ASCO Virtual Direct™ Highlights FEATURING Neha Mehta-Shah
390 views
July 22, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Related Content

AUTOPLAY
08:59
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "SWOG S1826 Trial - Nivo-AVD vs. Bv-AVD in O…

Feat. S. Rutherford
41:20
SOHO Highlights: State of the Art and Next Questions

SOHO Highlights - State of the Art & Next Questions: Hodgkin Lym…

Feat. N. Bartlett
15:18
UNC Lineberger Comprehensive Cancer Center

Hodgkin Lymphoma Management: Updates for 2023

Feat. N. Grover
30:24
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Treatment of Older Patients With HL in the …

Feat. A. Evens
42:09
University of Colorado Department of Medicine

Immunotherapy in Lymphomas: The Present and the Future

Feat. M. Kamdar
15:24
Total Health

2023 ASCO® Direct Philadelphia: Hodgkin Lymphoma Updates

Feat. J. Svoboda
10:21
SOHO 2023 Eleventh Annual Meeting

SOHO 2023 Next Questions: HL

Feat. A. Herrera
08:21
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "The Phase 2 KEYNOTE-B68 Trial - Efficacy …

Feat. A. Mcdonald
15:56
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

2024 Updates in Management of Hodgkin Lymphoma

Feat. J. Svoboda
08:30
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "PD-1 Blockade Before AutoSCT in R/R Classic…

Feat. S. Desai
15:19
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: Treatment of HL in Older Adults

Feat. J. Friedberg
36:24
SOHO Highlights: State of the Art and Next Questions

State of the Art and Next Questions: Hodgkin Lymphoma

Feat. A. Herrera
21:46
SOHO Turkey 2023

SOHO Turkey 2023: How I Treat Hodgkin Lymphoma

Feat. T. Toptas
06:50
ecancer

ASCO® 2023 Insights: "S1826 Study Summary - Nivolumab-AVD vs. B…

Feat. A. Herrera
31:25
Indy Hematology Review

Jumping on a Moving Bullet Train: Emerging Treatments for Hodgkin Ly…

Feat. M. Lunning
15:23
EHA 2022 Conference Coverage

Improved OS With 1L Brentuximab Vedotin + Chemo in Stage III/IV Clas…

Feat. J. Radford
19:27
Penn Medicine's 2023 Updates in Care of the Hematologic Malignancies Patient

Updates in Management of Hodgkin Lymphoma

Feat. J. Svoboda
19:51
UChicago Medicine

Update on Immunotherapy Efforts in cHL and DLBCL

Feat. J. Kline
13:38
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "S1826 Trial - Nivo-AVD Compared to Brentuxi…

Feat. S. Castellino
26:18
MyCancerHaven

Overview of the Diagnosis and Treatment of Hodgkin Lymphoma

Feat. R. Vij, T. Fenske